Ravuconazole
Ravuconazole (BMS-207147; ER-30346) is an orally available triazole antifungle agent that potently inhibits a wide range of fungi.
Product Specifications
CAS Number
182760-06-1
Product Name Alternative
BMS-207147; ER-30346
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Fungal
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection; Cancer
Assay Protocol
https://www.medchemexpress.com/Ravuconazole.html
Purity
99.91
Solubility
DMSO : ≥ 50 mg/mL
Smiles
FC1=CC(F)=CC=C1[C@](CN2C=NC=N2)(O)[C@@H](C)C3=NC(C4=CC=C(C#N)C=C4)=CS3
Molecular Formula
C22H17F2N5OS
Molecular Weight
437.47
Precautions
H315, H319, H335
References & Citations
[1]Hata K, et al. In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum.Antimicrob Agents Chemother. 1996 Oct;40 (10) :2237-42.|[2]Fung-Tomc JC, et al. In vitro activity of a new oral triazole, BMS-207147 (ER-30346) Antimicrob Agents Chemother. 1998 Feb;42 (2) :313-8.|[3]Hata K, et al. Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.Antimicrob Agents Chemother. 1996 Oct;40 (10) :2243-7.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSR030477-01 50 µg
Recombinant SARS-CoV-2 Spike Protein (RBD-SD1, His Tag)
Sign In for Pricing
View Details PKSR030477-02 1 mg
Recombinant SARS-CoV-2 Spike Protein (RBD-SD1, His Tag)
Sign In for Pricing
View Details 
BNC401790-500 1x 500 µL
CD79a (B-Cell Marker) (IGA/1790R), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details